ARCHIVES

Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Tobacco Research Council Awards Six New Grants

July 4, 1975

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

Group trials need prioritization, review, NCI official says.

July 25, 2003

Study: HPV Testing Can Predict Precancers For Nearly Two Decades Following Exam

August 31, 2012

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 14, 2000